InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Ferguson Matthew, Chief Financial Officer. Director active across 2 companies, notably Aziyo Biologics, INC.. Aggregated, 19 filings have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €64k. History available since 10 May 2021. The latest transaction was filed on 17 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ferguson Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
12,500 sharesClass A Common StockSEC:0001304079-26-000005:0
60,000 shares@ US$0.5316.1% of flowClass A Common StockSEC:0001304079-25-000008:0
Canonical exit: 17 Mar 2026 (T+90)
12,500 sharesClass A Common StockSEC:0001304079-25-000006:0
4,500 shares@ US$0.651.8% of flowClass A Common StockSEC:0001304079-25-000004:0
Canonical exit: 1 Mar 2026 (T+90)
29,000 sharesClass A Common StockSEC:0001410578-25-002228:0
12,500 sharesClass A Common StockSEC:0001415889-25-016993:0
1,287 sharesClass A Common StockSEC:0001415889-25-007697:0
12,500 sharesClass A Common StockSEC:0001415889-24-028994:0
29,500 sharesClass A Common StockSEC:0001415889-24-023299:0
50,000 sharesClass A Common StockSEC:0001415889-24-021194:0
105,080 shares@ US$1.4275100.0% of flowClass A Common StockSEC:0001415889-24-020441:0
25,000 sharesClass A Common StockSEC:0001415889-24-016513:0
1,288 shares0Class A Common StockSEC:0001415889-24-007995:0
70,053 sharesClass A Common StockSEC:0001415889-23-013473:0
1,287 shares0Class A Common StockSEC:0001415889-23-004624:0
6,000 shares@ US$4.0349.0% of flowClass A Common StockSEC:0001415889-22-012089:0
Canonical exit: 2 Mar 2023 (T+90)
13,874 sharesClass A Common StockSEC:0001415889-22-009542:0
1,288 shares0Class A Common StockSEC:0001415889-22-002860:0
1,300 shares@ US$11.1434.2% of flowClass A Common StockSEC:0001104659-21-065258:0
Canonical exit: 8 Aug 2021 (T+90)
19 of 19 declarations
About Ferguson Matthew
Ferguson Matthew is Chief Financial Officer and has filed 19 transactions in total. In the 19 recent filings sampled, the period runs from 2021-05-12 to 2026-03-12, with EUR 64481 of purchases and EUR 0 of sales, and the most frequent transaction nature is option exercise. He is reported at ELUTIA INC. and Aziyo Biologics, INC.
